TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06274047: PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A

Sponsor: M.D. Anderson Cancer Center · Phase: PHASE3 · Area: ONCOLOGY · Target Enrollment: 120 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$17,385,060

Rescue Site Savings

+$11,480,700

Unlock Full NCT06274047 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06274047 Rescue Dossier →